Gentian Diagnostics ASA – conversion to public limited liability company registered

07. May 2021 | 1 min read

Moss, 7 May 2021
Reference is made to the stock exchange announcement made on 4 May 2021 by Gentian Diagnostics AS (the "Company") regarding the annual general meeting held the same date.
The resolutions made by the general meeting, inter alia amendments to the Company's articles of association, including the conversion of the Company into a public limited liability company and change of company name have now been registered with the Norwegian Register of Business Enterprises. The new name of the Company is Gentian Diagnostics ASA.
 
For further information, please contact:
Hilja Ibert CEO, Gentian Diagnostics
E-mail: hilja.ibert@gentian.no 
Cell Phone: +47 919 05 242

Njaal Kind CFO, Gentian Diagnostics
E-mail: njaal.kind@gentian.no
Cell Phone. +47 919 06 525

You may also read


Apr 30, 2025 - Kristin Hart

Gentian Diagnostics: Invitation to presentation of first quarter results

Gentian Diagnostics ASA will present its first quarter 2025 results on 7 May 2025 at 10.00 CEST.

Apr 11, 2025 - Ole Sørlie

Gentian Diagnostics: Notice of annual general meeting

Gentian Diagnostics ASA’s annual general meeting will be held on Tuesday 6 May 2025 at 11:00 at the company’s..